Core Viewpoint - The announcement details the successful achievement of the first exercise conditions for the stock option and restricted stock incentive plan for 2024 by Meige Intelligent Technology Co., Ltd, allowing eligible participants to exercise their stock options [1][4][10]. Summary by Sections Incentive Plan Approval Process - The company held its fourth board meeting on July 10, 2025, where it approved the first exercise conditions for the stock option incentive plan [1]. - The plan underwent multiple approvals, including a public notice period from June 1 to June 10, 2024, during which no objections were raised [2]. Exercise Conditions Achievement - The first exercise period for the stock options is set from July 1, 2024, to June 30, 2026, with 40% of the total options granted eligible for exercise [5]. - The total number of options available for exercise in this period is 631,200 [5]. - The company confirmed that it did not encounter any disqualifying events in the last fiscal year, allowing the exercise conditions to be met [5][10]. Performance Assessment - The performance targets for the first exercise period include a minimum revenue growth of 30% compared to the previous year, with the actual net profit for 2024 projected at approximately 146.69 million yuan, reflecting a growth rate of 127.39% [5][10]. - The assessment of individual performance for the 156 participants showed that all but four met the necessary criteria, allowing them to exercise their options [6]. Adjustments and Cancellations - Adjustments were made to the exercise price of the stock options from 21.10 yuan to 20.97 yuan due to a cash dividend distribution [7]. - The company plans to cancel stock options for individuals who no longer meet the eligibility criteria due to resignation, totaling 14,000 options [8]. Impact of the Exercise - The exercise of stock options is not expected to significantly alter the company's shareholding structure or listing conditions [10]. - The financial implications of the stock option exercise will be accounted for in accordance with relevant accounting standards, potentially increasing the company's capital reserves [10]. Legal Opinions and Compliance - Legal counsel confirmed that the company has obtained the necessary authorizations for the exercise of stock options, affirming compliance with the incentive plan's conditions [11].

深圳市芭田生态工程股份有限公司第八届监事会第二十二次会议决议公告 证券代码:002170 证券简称:芭田股份 公告编号:25-45 深圳市芭田生态工程股份有限公司 本公司及监事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 一、监事会会议召开情况 深圳市芭田生态工程股份有限公司（以下简称"公司"）第八届监事会第二十二 次会议于 2025 年 7 月 9 日（星期三）在公司本部 V1 会议室以现场和通讯方式结合召 开。本次会议的通知于 2025 年 7 月 4 日以电子邮件、电话、微信等方式送达。本届监 事会共有 3 名监事，应参加会议的监事 3 名，实际参加会议的监事 3 名，公司高级管 理人员列席了本次会议。本次会议的召开程序符合《公司法》《证券法》及《公司章 程》等有关法律法规的规定。 二、监事会会议审议情况 （一）审议通过《关于调整 2022 年股票期权与限制性股票激励计划行权价格的议 案》； 经审查，监事会认为： 公司此次调整 2022 年股票期权与限制性股票激励计划（以下简称"本次激励计划"） 中首次及预留授予股票期权行权价格符合《上市公司股权激励管理办法》（以 ...

Core Viewpoint - Foxconn Industrial Internet Co., Ltd. has reported on the stock option and restricted stock incentive plan for 2019, detailing the exercise of stock options and the status of shares as of the second quarter of 2025. Group 1: Stock Option Exercise Details - The number of stock options exercisable in the fifth exercise period of the 2019 incentive plan is 13,265 shares, representing 0.39% of the total exercisable options for that period. As of April 30, 2025, a total of 3,242,376 shares have been exercised, accounting for 94.49% of the total options available for exercise in that period [1][16]. - For the portion of reserved stock options in the fifth exercise period, 46,960 options are available, with 1,680 shares exercised in the second quarter of 2025, which is 3.58% of the total options for that period [1][16]. - The remaining reserved stock options in the fifth exercise period total 941,750, with 587,374 shares exercised, representing 62.37% of the total options available for that period [1][16]. Group 2: Decision-Making and Disclosure Process - The decision-making process for the stock option exercise involved multiple meetings where independent directors and the supervisory board provided their opinions and legal advice was obtained from Beijing King & Wood Mallesons [1][16]. - The company has disclosed relevant information regarding the stock option and restricted stock incentive plan through the Shanghai Stock Exchange and other designated media [1][16]. Group 3: Impact on Financials and Share Structure - The total funds raised from this incentive plan amount to 5,927,421.28 yuan, which will be used to supplement the company's working capital [1][17]. - The exercise of stock options will result in an increase of 602,319 shares in the company's total share count, bringing the total to 19,859,465,126 shares, with no change in the controlling shareholder [1][17].

Group 1 - The company held its third independent director meeting on July 2, 2025, with all three independent directors present, confirming the legality and validity of the meeting procedures [1][2] - The meeting approved the proposal regarding the conditions for the second exercise period of stock options and the lifting of restrictions on the second lock-up period for restricted stock under the 2023 stock option and restricted stock incentive plan [1][2] - The independent directors agreed to submit the proposal to the board of directors for further review [1][2] Group 2 - The meeting also approved the proposal to cancel a portion of stock options under the 2023 stock option and restricted stock incentive plan due to reasons such as employee resignation, death, performance assessment results, and expiration without exercise [2] - The cancellation process was deemed legal and compliant with relevant regulations, ensuring no harm to the company or its shareholders [2] - This proposal will also be submitted to the board of directors for consideration [2]

Core Viewpoint - The announcement details the results of the stock option and restricted stock incentive plan for the second quarter of 2025, indicating no shares were exercised during this period. Summary by Sections Stock Option Exercise Results - The total number of stock options available for exercise in the third exercise period of the 2021 stock option and restricted stock incentive plan is 1,976,997 shares, with the exercise start date on January 17, 2025. As of June 30, 2025, no shares have been exercised, representing 0% of the total available for this period [1][12]. - For the reserved stock options in the second exercise period, the total available is 738,491 shares, with the exercise start date on December 25, 2024. Similarly, no shares have been exercised as of June 30, 2025, also representing 0% of the total available [1][12]. Decision-Making Process and Disclosure - The decision-making process for the stock option exercise involved independent directors providing consent and avoiding conflicts of interest during the voting on related proposals [2][3]. Stock Option and Restricted Stock Plan Adjustments - The number of incentive participants was adjusted from 327 to 302 due to 25 participants voluntarily giving up their participation. The total number of stock options remains at 3,865,060, with a grant price of 32.26 CNY per option and restricted stock at 16.13 CNY per share [6][7]. Stock Listing and Trading Arrangements - The stock options from the third exercise period and the reserved options from the second exercise period will be exercised through a self-exercise method, with shares listed for trading on the second trading day after the exercise date [11][12]. Impact on Financial Reports - The exercise of stock options is not expected to have a significant impact on the company's financial condition or operating results [14].

证券代码：600654 证券简称：中安科 公告编号：2025-050 中安科股份有限公司 关于 2023 年股票期权与限制性股票激励计划 2025 年 第二季度自主行权结果暨股份变动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ? 本次行权股票数量：2025 年第二季度，中安科股份有限公司（以下简称 "公司"）《2023 年股票期权与限制性股票激励计划》（以下简称"本激励 计划""激励计划"）首次授予股票期权第一个行权期行权且完成股份过户 登记的期权数量合计为 100 股，占第一个行权期可行权股票期权总数的 ? 截至 2025 年第二季度末，公司《激励计划》首次授予股票期权第一个行 权期累计行权且完成股份过户登记的行权股票数量为 2,488,560 股，占第一 个行权期可行权股票期权总数的 99.59%。 ? 本次行权股票上市流通时间：采用自主行权模式，激励对象行权所得股 票于行权日（T 日）后的第二个交易日（T+2）日上市交易。 一、本激励计划已履行的决策程序及相关信息披露 于 <公司 ensp="e ...

转债代码：113633 转债简称：科沃转债 科沃斯机器人股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 届董事会第二次会议在公司会议室召开。本次会议的会议通知已于 2025 年 6 月 董事 9 名，实到董事 9 名（其中：以通讯表决方式出席会议 4 名），符合召开董 事会会议的法定人数。会议由公司董事长钱东奇先生主持，公司高级管理人员列 席了会议。会议的召集、召开符合有关法律、行政法规、部门规章、规范性文件 和《公司章程》的规定，表决形成的决议合法、有效。会议审议并通过了如下议 案: 证券代码：603486 证券简称：科沃斯 公告编号：2025-048 君合律师事务所上海分所出具了《关于科沃斯机器人股份有限公司 2024 年 股票期权与限制性股票激励计划调整及预留授予事项的法律意见书》。 上海荣正企业咨询服务（集团）股份有限公司出具了《关于科沃斯机器人股 份有限公司 2024 年股票期权与限制性股票激励计划调整及预留授予相关事项之 独立财务顾问报告》。 表决结果：同意 8 票、反对 0 ...

中国上海石门一路 288 号兴业太古汇香港兴业中心一座 26 层 邮编：200041 电话：（86-21）5298 5488 传真：（86-21）5298 5492 junhesh@junhe.com 君合律师事务所上海分所 关于科沃斯机器人股份有限公司 法律意见书 科沃斯机器人股份有限公司： 《证券法》 君合律师事务所上海分所（以下简称"本所"）为具有从事法律业务资格的 律师事务所分所。本所接受科沃斯机器人股份有限公司（以下简称"公司"或 "科沃斯"）的委托，委派本所律师以特聘法律顾问的身份，就公司 2024 年股 票期权与限制性股票激励计划预留部分授予（以下简称"本次激励计划预留授 予"）相关事宜出具本法律意见书。 本法律意见书系根据《中华人民共和国公司法》 （以下简称"《公司法》"）、 《中华人民共和国证券法》 （以下简称"《证券法》"）、中国证券监督管理委员 会（以下简称"中国证监会"）颁布的《上市公司股权激励管理办法》（以下简 称"《管理办法》"）等在本法律意见书出具日以前中国（仅为出具本法律意见 书之目的，不包括香港特别行政区、澳门特别行政区和台湾地区）正式公布并实 施的法律、法规及规范性文件和《 ...

Core Viewpoint - The company has approved the 2025 Stock Option and Restricted Stock Incentive Plan, which aims to motivate and retain key personnel through equity incentives [1][4]. Group 1: Incentive Plan Details - The company held meetings on June 12, 2025, to review and approve the incentive plan and its management measures [1]. - The incentive plan includes stock options and restricted stocks, with details published on June 13, 2025 [2]. - The public disclosure of the incentive plan included the names and positions of the incentive targets, which were made available internally from June 13 to June 22, 2025 [2]. Group 2: Verification Process - The supervisory board verified the names, identification documents, and employment contracts of the incentive targets [3]. - No objections were raised by employees regarding the incentive targets during the public disclosure period [2][4]. Group 3: Supervisory Board's Opinion - The supervisory board confirmed that the selected incentive targets meet the qualifications set forth in relevant laws and regulations [4][5]. - The incentive targets do not fall under any disqualifying conditions as outlined in the management regulations [5]. - The targets include directors, senior management, middle management, and core personnel who have formal employment relationships with the company [5].

Core Viewpoint - The legal opinion letter from Beijing Hairun Tianrui Law Firm confirms that Dingjie Shuzhi Co., Ltd. has properly adjusted the stock option and restricted stock incentive plan for 2021, specifically regarding the grant price of restricted stocks, in compliance with relevant laws and regulations [2][12]. Group 1: Legal Compliance and Procedures - The law firm acted as a special legal advisor for Dingjie Shuzhi's 2021 stock option and restricted stock incentive plan [2]. - The adjustment of the grant price for restricted stocks has been conducted in accordance with the Company Law, Securities Law, and the Management Measures for Equity Incentives of Listed Companies [2][12]. - The necessary decision-making procedures for the incentive plan have been fulfilled, including approvals from the board of directors and the supervisory board [6][10]. Group 2: Adjustment Details - The adjustment of the grant price for restricted stocks is calculated as follows: P = P0 - V, where P0 is the original grant price, V is the dividend per share, and P is the adjusted grant price [12]. - The adjusted grant price for the reserved restricted stocks is set at 10.77 yuan per share after accounting for a dividend of 0.03 yuan per share [12]. - The adjustment falls within the authorization granted by the company's first extraordinary general meeting in 2021, thus does not require further shareholder approval [12]. Group 3: Conclusion - The law firm concludes that the adjustment has obtained the necessary approvals and is in compliance with the company's incentive plan and relevant legal regulations [12].